Orchestra BioMed Holdings, Inc. Retained Earnings
Orchestra BioMed Holdings, Inc. (OBIO) had Retained Earnings of -$407.02 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-10
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$407.02M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$383.27M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$362.58M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$368.82M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$407.02M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$383.27M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$362.58M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$368.82M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$348.00M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$328.63M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | -$309.88M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$293.72M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$278.30M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$262.32M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$248.85M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$236.04M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$222.72M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$210.67M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$199.73M 10-K · filed 2024-03-27 | -$6.95M 10-K · filed 2023-01-25 |
| 2022-09-30 | -$6.07M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$5.25M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$4.38M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$3.94M 10-K · filed 2023-01-25 | |
| 2021-09-30 | -$3.85M 10-Q/A · filed 2022-03-31 | |
| 2021-06-30 | -$373.87K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$281.54K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$3.56M 10-K · filed 2022-03-31 | -$173.54K 10-K · filed 2021-03-10 |
| 2020-09-30 | -$81.43K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |